What You Should Know:
– Women’s Health Access Matters (WHAM), a non-profit organization, in collaboration with the KPMG Foundation and KPMG LLP, has released a new report, “The Business Case for Accelerating Women’s Health Investment.”
– Launched at the 43rd Annual JPMorgan Healthcare Conference in San Francisco, the report highlights the immense growth potential and economic returns within the women’s health sector.
The report launch coincides with the launch of WHAM’s Investment Collaborative, an initiative aimed at doubling venture funding for women-founded companies and accelerating innovation in diagnostics, treatments, and prevention.
Redefining Women’s Health
The WHAM Investment Report expands the traditional definition of women’s health to encompass a broader range of conditions, including those that:
- Exclusively affect women: Menopause, ovarian cancer, etc.
- Disproportionately affect women: Autoimmune diseases, Alzheimer’s, etc.
- Differently affect women: Cardiovascular and lung diseases, etc.
Untapped Market with Massive Growth Potential
The report highlights the significant growth opportunities within the women’s health market:
- $30 Billion Market by 2030: The market for conditions disproportionately affecting women is rapidly expanding.
- 95% Untapped Market: Only 5% of conditions are exclusive to women, leaving a vast untapped market for innovation and investment.
- 300% Investment Growth: Despite recent growth, women’s health still receives only 2% of healthcare VC funding, indicating significant room for expansion.
3Not30 Initiative
WHAM is also driving the 3Not30 Initiative, a three-year campaign focused on:
- Increasing private and federal investment in women’s health.
- Expanding access to clinical trials for women.
- Mining data and establishing WHAM Accountability Indexes to track progress.
“Investing in the health of women is one of the most compelling business opportunities of our time,” said Carolee Lee, Founder and CEO of WHAM and TIME100 Global Health Leader. “Women comprise over half the global population and drive 80% of healthcare spending decisions, yet their health needs remain underfunded. This report presents a clear roadmap for prioritizing investment in women’s health—a sector with immediate ROI and exponential growth potential.”